Related Experiment Videos
Effects of DFMO-induced polyamine depletion on human tumor cell sensitivity to antineoplastic DNA-crosslinking drugs
Abstract:
We investigated the effect of pretreatment with difluoromethylornithine (DFMO), an ornithine decarboxylase inhibitor, on the cytocidal responses of four human adenocarcinoma cell lines to two alkylating and crosslinking agents: chlorambucil and N,N',N"-triethylenethiophosphoramide (thiotepa). The cell lines studied included HuTu-80 (duodenum), HT-29 (colon), ME-180 (cervix), and A-427 (lung). A 48- to 72-h pretreatment with DFMO reduced intracellular putrescine and spermidine contents to less than 10% and less than 1% of control levels. This treatment also caused a 30%-70% decline in spermine content. Survival of control and DFMO-pretreated cells after treatment with chlorambucil or thiotepa was measured by a plating efficiency assay. For three of the four lines studied, the DFMO-induced partial polyamine depletion significantly protected cells from the lethal effects of chlorambucil. In ME-180 cultures alone, DFMO pretreatment did not alter the cytocidal efficacy of chlorambucil. Addition of exogenous putrescine to cultures of HuTu-80, HT-29, or A-427 24 h after DFMO addition but 24 h before treatment with chlorambucil reversed the polyamine depletion and its protective effects on chlorambucil-induced cell kill. In contrast to the above observations, DFMO and partial polyamine depletion had no effect on cell survival after thiotepa treatment for any of the cell lines investigated.
Insights
Difluoromethylornithine (DFMO) pretreatment partially depleted polyamines, protecting some adenocarcinoma cells from chlorambucil but not thiotepa. Restoring polyamines reversed this protective effect against chlorambucil.
Area of Science:
- Oncology
- Molecular Pharmacology
- Biochemistry
Background:
- Polyamines are essential for cell growth and proliferation.
- Ornithine decarboxylase (ODC) is the rate-limiting enzyme in polyamine biosynthesis.
- Alkylating agents like chlorambucil and thiotepa are used in cancer chemotherapy.
Purpose of the Study:
- To investigate the impact of difluoromethylornithine (DFMO)-induced polyamine depletion on the efficacy of chlorambucil and thiotepa against human adenocarcinoma cell lines.
- To determine if polyamine levels influence cellular response to these chemotherapeutic agents.
Main Methods:
- Human adenocarcinoma cell lines (HuTu-80, HT-29, ME-180, A-427) were pretreated with DFMO (an ODC inhibitor) for 48-72 hours.
- Intracellular polyamine levels (putrescine, spermidine, spermine) were quantified.
- Cell survival after treatment with chlorambucil or thiotepa was assessed using a plating efficiency assay.
- Reversal studies involved adding exogenous putrescine after DFMO treatment.
Main Results:
- DFMO pretreatment significantly reduced putrescine and spermidine levels, and decreased spermine content in all cell lines.
- DFMO-induced polyamine depletion conferred significant protection against chlorambucil in three of four cell lines (HuTu-80, HT-29, A-427).
- DFMO did not alter chlorambucil efficacy in ME-180 cells.
- Addition of exogenous putrescine reversed the protective effect of DFMO against chlorambucil.
- DFMO and polyamine depletion had no impact on cell survival following thiotepa treatment.
Conclusions:
- Partial polyamine depletion via DFMO can modulate cellular sensitivity to chlorambucil in certain human adenocarcinoma cell lines.
- Polyamines play a role in mediating the cytocidal effects of chlorambucil.
- DFMO's effect is agent-specific, as it did not influence thiotepa efficacy.
- Restoration of polyamine levels can overcome DFMO-mediated protection, highlighting the critical role of polyamines in drug response.